Ebola outbreak in the Democratic Republic of Congo surpasses 9,000 confirmed cases

12:52

By: Azzat Manal

Ebola outbreak in the Democratic Republic of Congo surpasses 9,000 confirmed cases

The Ebola outbreak in the Democratic Republic of the Congo (DRC) continues to escalate, with more than 9,200 confirmed cases and 4,400 related deaths reported by mid-October 2026. According to the latest figures cited by the European Centre for Disease Prevention and Control, the country had recorded 9,277 confirmed infections and 4,478 deaths as of October 15, based on data through October 14. The outbreak has become the largest and deadliest Ebola epidemic recorded in the country's history. <Link url="https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-week-42-2026.pdf" title="Source: ECDC epidemiological report"/>.

Ituri province, in the country's northeast, remains the main centre of transmission. The virus has also spread to several other provinces, placing additional pressure on health facilities and response teams. The outbreak has affected dozens of health zones, while insecurity, population movements and limited medical infrastructure complicate efforts to identify infections, trace contacts and provide timely care.

The current epidemic is caused by the Bundibugyo strain of the Ebola virus. Unlike the Zaire strain, for which an approved vaccine is available, Bundibugyo has no specifically approved vaccine or treatment. This gap presents a major challenge for health authorities seeking to reduce mortality and limit further transmission.

Researchers are working to develop and assess preventive tools suited to the strain responsible for the outbreak. The World Health Organization and its partners have announced plans for clinical research in the DRC, including an initiative intended to evaluate vaccine candidates. The Ervebo vaccine, which is approved against the Zaire strain, has also been used in research involving frontline volunteers, but its effectiveness against Bundibugyo cannot be assumed.

The distinction between Ebola strains is important because vaccines and other medical interventions do not necessarily offer the same protection against every variant. In the meantime, the response relies heavily on surveillance, laboratory testing, isolation of suspected and confirmed cases, contact tracing, infection prevention in healthcare settings and communication with affected communities.

The scale of the current outbreak exceeds the major Ebola epidemic that struck the DRC between 2018 and 2020, which caused approximately 2,300 deaths among around 3,500 reported cases. The latest emergency has also raised regional concerns after infections linked to the outbreak in the DRC were reported in Kenya, highlighting the importance of cross-border monitoring and coordination.

The continuing rise in infections and deaths underscores the urgent need to strengthen healthcare capacity and accelerate research into tools specifically suited to the Bundibugyo strain. Health authorities and international partners face the dual challenge of containing transmission in affected communities while improving access to early diagnosis and supportive care. The effectiveness of these efforts will depend on sustained coordination, reliable surveillance and cooperation with the populations most affected by the epidemic.